Rifampin: all 278 studies that test it
Page 3 of 3. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.
- A Study for Improving the Outcome of Childhood Acute Promyeloid LeukemiaCompletedNCT02200978Phase 4
- Study to Evaluate the Effect of Multiple Doses of Rifampicin on the Multiple-dose Pharmacokinetics of Linagliptin in Healthy VolunteersCompletedNCT02183584Phase 1
- Relative Bioavailability of Single Doses of Dabigatran Etexilate in Healthy VolunteersCompletedNCT02173717Phase 1
- High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding StudyCompletedNCT02169882Phase 2/3
- A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in MenCompletedNCT02138799Phase 1
- The Effects of Rifampin on the Pharmacokinetics of RosuvastatinCompletedNCT02106767Phase 1
- Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of DaptomycinCompletedNCT02097953Early Phase 1
- A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or BupropionCompletedNCT02085967Phase 1
- A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or DonepezilCompletedNCT02055703Phase 1
- To Assess the Effect of Rifampicin on the Pharmacokinetics of Selumetinib in Healthy Male VolunteersCompletedNCT02046850Phase 1
- A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199WithdrawnNCT01969682Phase 1
- A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive TumorsCompletedNCT01954043Phase 1
- A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991)CompletedNCT01953731Phase 1
- Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145CompletedNCT01947777Phase 1
- A Pilot Study for Pharmacokinetic Parameter of Colchicine in Patient Taking RifampinCompletedNCT01932268Phase 2
- Study to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid TumoursCompletedNCT01929603Phase 1
- Effects of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sublingual and Intravenous BuprenorphineCompletedNCT01854489Phase 4
- Immune Activation and Drug Absorption in HIV-Infected PatientsCompletedNCT01845298Not applicable
- A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy VolunteersCompletedNCT01814709Phase 1
- Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous PreparationCompletedNCT01802502Phase 2
- Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment OutcomesStatus unknownNCT01782950Phase 4
- A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult SubjectsCompletedNCT01768663Phase 1
- A Study to Assess the Effect of Rifampin on the Pharmacokinetics of PCI-32765 in Healthy ParticipantsCompletedNCT01763021Phase 1
- Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A ActivityCompletedNCT01760642Phase 1
- Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer InfectionTerminatedNCT01756924Phase 2
- The Effect of PXR Activation on Blood Pressure RegulationCompletedNCT01690104Phase 4
- A Study to Investigate the Effects of Rifampicin on the Pharmacokinetics of Aleglitazar in Healthy VolunteersCompletedNCT01679639Phase 1
- A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male ParticipantsCompletedNCT01655147Phase 1
- Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin.CompletedNCT01637636Phase 1
- A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy VolunteersCompletedNCT01591850Phase 1
- Colistin and Rifampicin for MDR-AcinetobacterCompletedNCT01577862Phase 3
- Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or RifampinCompletedNCT01571414Phase 1
- Treatment of Methicillin-sensitive Staphylococcus Aureus (MSSA)CompletedNCT01500837Not applicable
- Safety and Pharmacokinetics of Single and Multiple Dose Rifampin in InfantsTerminatedNCT01441206Phase 1
- Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) ColonizationCompletedNCT01438515Not applicable
- Pharmacokinetic Drug Interaction Study in Healthy Male SubjectsCompletedNCT01426906Phase 1
- The Effect of Intermittent Rifampicin on RaltegravirCompletedNCT01424826Phase 1
- To Evaluate if Multiple Doses of Rifampicin Change the Blood Concentration of YM150 (Darexaban)CompletedNCT01406002Phase 1
- A Study to Evaluate the Effects of Rifampin on Single-Dose Pharmacokinetics of Canagliflozin in Healthy VolunteersCompletedNCT01395927Phase 1
- Reintroduction Regimens After Hepatitis During Anti-tuberculosis TreatmentStatus unknownNCT01395654Phase 4
- Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TBCompletedNCT01392911Phase 2
- Genetic Variability in the Response to Warfarin at Baseline and During Induction of CYP2C9Status unknownNCT01388075Not applicable
- TMC207 +/- Rifabutin/RifampinCompletedNCT01341184Phase 1
- Cholesterol Metabolites as Markers for CYP3A InductionCompletedNCT01340456Not applicable
- Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.CompletedNCT01336218Phase 1
- Colistin Plus Rifampicin in MDR P. Aeruginosa and A. BaumaniiStatus unknownNCT01297855Phase 3
- Effects of Pregnane X Receptor (PXR) Activation on Human Glucose, Lipid and Hormone HomeostasisCompletedNCT01293422Phase 4
- Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female VolunteersCompletedNCT01231542Phase 1
- Early Bactericidal Activity (EBA) of SQ109 in Adult Subjects With Pulmonary TBCompletedNCT01218217Phase 2
- A Study to Assess the Effect of Rifampin on the Metabolism of NavitoclaxCompletedNCT01121133Phase 1
- Trial Comparing Efficacy of Treatments for Hidradenitis SuppurativaCompletedNCT01063270Not applicable
- CYP2C9 Activity Evaluated With a Simple Finger PrickCompletedNCT01026714Phase 1/2
- Study of VX-770 and Rifampin in Healthy Male SubjectsCompletedNCT01018368Phase 1
- Drug-Drug Interaction Study With RifampinCompletedNCT01002079Phase 1
- Pregnane X Receptor (PXR) Agonist Rifampicin Effects on Glucose, Lipid and Hormone HomeostasisCompletedNCT00985270Phase 4
- Interplay Between Organic Anion Transporting Polypeptide (OATP) Transporters Transporters and CYP2C9 in Glyburide Pharmacokinetics (PK)WithdrawnNCT00935363Phase 1
- Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectivenessCompletedNCT00931736Phase 3
- Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat TuberculosisCompletedNCT00816426Phase 1
- Pharmacokinetic Interaction Study to Assess the Effect of Repeat Doses of Rifampin on Mirabegron (YM178) in Healthy VolunteersCompletedNCT00776516Phase 1
- TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing.CompletedNCT00741169Phase 1
- A Pilot Study of Inflammatory Markers in Alzheimer's DiseaseStatus unknownNCT00715858Phase 3
- Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) InfectionCompletedNCT00711854Phase 4
- Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated TuberculosisCompletedNCT00698334Phase 3
- Healthy Volunteer Study of Clopidogrel and RifampicinCompletedNCT00696566Phase 1
- Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung DiseaseCompletedNCT00598962Phase 4
- Controlled Trial: 5-day Course of Rifampin Versus Doxycycline for the Treatment of Mild to Moderate Scrub TyphusCompletedNCT00568711Not applicable
- A Study of the Interaction of Rifampin and Vinflunine in Subjects With Advanced CancerWithdrawnNCT00534807Phase 1
- Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal FluidCompletedNCT00439166Phase 3
- A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).CompletedNCT00405080Phase 1
- Study to Determine the Impact of Multiple Doses of Rifampin on Single-dose Pharmacokinetics of HCV-796CompletedNCT00384280Phase 1
- Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA InfectionCompletedNCT00304811Phase 4
- Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD TreatmentCompletedNCT00182429Phase 3
- Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)CompletedNCT00170209Phase 3
- Clinical Trial of Rifampin and Azithromycin for the Treatment of River BlindnessCompletedNCT00127504Phase 2
- Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected AdultsCompletedNCT00096850Not applicable
- Tuberculosis Prevention for HIV Infected AdultsCompletedNCT00057122Phase 3
- TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or IntoleranceCompletedNCT00023374Not applicable
- A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.CompletedNCT00000641Phase 2